Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Laboratoires Thea
The primary objectives are to compare the safety and the efficacy of Geltim LP® 1mg/g eye drops versus Xalatan® eye drops with respect to:
The assessment of the ocular tolerance:
* Ocular symptoms
* Objective ocular signs.
The maintain of the IOP efficient lowering effect. Comparison between the 2 study products of the mean basal IOP after a 12 weeks treatment period (84 days ±7).
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Written informed consent.
Association of the 4 following criteria:
1. \- Bilateral primary open angle glaucoma or bilateral ocular hypertension already treated and controlled by mono-therapy of Xalatan® (1drop per day),
2. \- With local intolerance signs.
You may not be if
Presence of severe objective ocular sign.
Any ocular hypertension other than primary ocular hypertension or primary chronic open angle glaucoma (such as congenital, angle closure glaucoma, secondary glaucoma).
Absolute defect in the ten degrees central point of the visual field.
